Business Description
Revolution Medicines Inc
NAICS : 325411
SIC : 2833
ISIN : US76155X1182
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 17.87 | |||||
Equity-to-Asset | 0.89 | |||||
Debt-to-Equity | 0.06 | |||||
Debt-to-EBITDA | -0.15 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 29.81 | |||||
Beneish M-Score | -15.52 | |||||
WACC vs ROIC |
Growth Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -49.3 | |||||
3-Year EBITDA Growth Rate | -27 | |||||
3-Year EPS without NRI Growth Rate | -24.3 | |||||
3-Year FCF Growth Rate | -19 | |||||
3-Year Book Growth Rate | 15.9 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate | -4.58 |
Momentum Rank
6/10
Name | Current | Vs Industry | Vs History |
---|
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 14.24 | |||||
Quick Ratio | 14.24 | |||||
Cash Ratio | 13.98 | |||||
Days Sales Outstanding | 667.85 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -35.2 | |||||
Shareholder Yield % | -0.24 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -88031.94 | |||||
Net Margin % | -76423.32 | |||||
ROE % | -37.43 | |||||
ROA % | -33.26 | |||||
ROIC % | -322.27 | |||||
3-Year ROIIC % | -463.85 | |||||
ROC (Joel Greenblatt) % | -640.1 | |||||
ROCE % | -37.91 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | N/A | |||||
PE Ratio without NRI | N/A | |||||
PS Ratio | 11246.52 | |||||
EV-to-FCF | -15.84 | |||||
FCF Yield % | -0.24 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:RVMDW
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Revolution Medicines Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | 0 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 0 | ||
14-Day ATR ($) | 0 | ||
20-Day SMA ($) | 0 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range ($) | 0 - 1.05 | ||
Shares Outstanding (Mil) |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Revolution Medicines Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Revolution Medicines Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Revolution Medicines Inc Frequently Asked Questions
What is Revolution Medicines Inc(RVMDW)'s stock price today?
When is next earnings date of Revolution Medicines Inc(RVMDW)?
Does Revolution Medicines Inc(RVMDW) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |